Inactive Instrument

REMSleep Holdings Inc Stock Other OTC

Equities

US48583T1007

Medical Equipment, Supplies & Distribution

End-of-day quote Other OTC
- USD - Intraday chart for REMSleep Holdings Inc
Sales 2022 0.32 Sales 2023 0.2 Capitalization 22.66M
Net income 2022 -1M Net income 2023 -1M EV / Sales 2022 52,643,021 x
Net cash position 2022 1.39M Net cash position 2023 541K EV / Sales 2023 108,552,367 x
P/E ratio 2022
-9.04 x
P/E ratio 2023
-12.7 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 96.36%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 77 07-06-05
Chief Tech/Sci/R&D Officer 63 18-06-30
Members of the board TitleAgeSince
Chief Executive Officer 77 07-06-05
More insiders
REMSleep Holdings, Inc. is a medical technology company. The Company is focused on the development and commercialization of solutions for patients with obstructive sleep apnea. Its DeltaWave CPAP interface (the DeltaWave), which is a device to treat patients with sleep apnea. The patent-pending DeltaWave product is a nasal-pillow type interface that is designed with airflow characteristics to enable patients with sleep apnea to breathe normally. Its product is manufactured by mold makers. It has molds made in China. Its target market includes sleep product distributors that distribute its product; home care dealers; private sleep labs; product end users; physicians, particularly sleep physicians; medical groups; hospitals, and medical associations, such as the American Academy of Sleep Medicine and the American Sleep Association.
More about the company